Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum

Prostate

Volumn 72, Issue 2, 2012, Pages 186-192

  Briganti, Alberto ^a   Suardi, Nazareno ^a   Capogrosso, Paolo ^a   Passoni, Niccolò ^a   Freschi, Massimo ^b   Di Trapani, Ettore ^a   Gallina, Andrea ^a   Capitanio, Umberto ^a   Abdollah, Firas ^a   Tutolo, Manuela ^a   Bianchi, Marco ^a   Salonia, Andrea ^a   Da Pozzo, Luigi Filippo ^c   Montorsi, Francesco ^a   Rigatti, Patrizio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

landing sites; lymph node invasion; prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER SURGERY; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; HIGH RISK PATIENT; HUMAN; ILIAC LYMPH NODE; LYMPH FLOW; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHORREA; MALE; METASTASIS RESECTION; PARAAORTIC LYMPH NODE; PELVIS; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RETROPERITONEUM; SURGICAL APPROACH; WOUND DEHISCENCE;

AGED; HISTOCYTOCHEMISTRY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; PERITONEUM; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS;

EID: 84455170787     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21420     Document Type: Article

References (20)

1. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 61-71.
2. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-2499. (Pubitemid 36706536)
3. Schiavina R, Scattoni V, Castellucci P, et al. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: Comparison with clinical staging nomograms. Eur Urol 2008; 54: 392-401.
4. Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 2009; 55: 1251-1265.
5. Heidenreich A, Varga Z, Von Knobloch R,. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis. J Urol 2002; 167: 1681-1686. (Pubitemid 34240702)
6. Bader P, Burkhard FC, Markwalder R, et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer ? J Urol 2002; 168: 514-518. (Pubitemid 34793284)
7. Briganti A, Chun FK, Salonia A, et al. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology 2007; 69: 147-151. (Pubitemid 46161677)
8. Park JM, Charnsangavej C, Yoshimitsu K, et al. Pathways of nodal metastasis from pelvic tumors: CT demonstration. Radiographics 1994; 14: 1309-1321.
9. Brossner C, Ringhofer H, Hernady T, et al. Lymphatic drainage of prostatic transition and peripheral zones visualized on a three-dimensional workstation. Urology 2001; 57: 389-393. (Pubitemid 32140837)
10. Mattei A, Fuechsel FG, Bhatta Dhar N, et al. The template of the primary lymphatic landing sites of the prostate should be revisited: Results of a multimodality mapping study. Eur Urol 2008; 53: 118-125. (Pubitemid 350166722)
11. Scattoni V, Picchio M, Suardi N, et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: Results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 2007; 52: 423-429. (Pubitemid 46963456)
12. Bochner BH, Choi D, Herr HW, et al. Prospectively packaged lymph node dissections with radical cystectomy. Evaluation of node count variability and node mapping. J Urol 2004; 172: 878-881.
13. Ganswindt U, Schilling D, Muller AC, et al. Distribution of prostate sentinel nodes: A SPECT-derived anatomic atlas. Int J Radiat Oncol Biol Phys 2011; 79: 1364-1372.
14. Ganswindt U, Paulsen F, Corvin S, et al. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based intensity-modulated radiation therapy technique. Int J Radiation Oncology Biol Phys 2007; 67: 347-355. (Pubitemid 46108338)
15. Shih HA, Harisinghani M, Zietman AL, et al. Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiation Oncology Biol Phys 2005; 63: 1262-1269. (Pubitemid 41505308)
16. Sobin LH, Gospodariwicz M, Wittekind C,. (editors). TNM classification of malignant tumors. UICC International Union Against Cancer. 7th edition. Hoboken, NJ, USA: Wiley-Blackwell; 2009. pp. 243-248.
17. Leissner J, Ghoneim MA, Abol-Enin H, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: Results of a prospective multicenter study. J Urol 2004; 171: 139-144. (Pubitemid 37549109)
18. Briganti A, Karnes JR, Da Pozzo LF, et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol 2009; 55: 261-270.
19. Schumacher MC, Burkhard FC, Thalmann GN,. et al. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 2008; 54: 344-352.
20. Pagliarulo V, Hawes D, Brands FH, et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol 2006; 24: 2735-2742. (Pubitemid 46630570)